Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Gastroenterology

• Publication date

  2001-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/GAST.2001.27024PMID 11522749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C virus infection in a community in the Nile Delta: Risk factors for seropositivity

  2001cited by this paper
• Differential CD4+ and CD8+ T‐cell responsiveness in hepatitis C virus infection

  2001cited by this paper
• Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C

  2000cited by this paper
• Host genetic factors influence disease progression in chronic hepatitis C

  2000cited by this paper
• The global status of schistosomiasis and its control.

  2000cited by this paper
• The epidemiology of schistosomiasis in Egypt: Assiut governorate.

  2000cited by this paper
• Hepatitis C virus (HCV) infection in a community in the nile delta: Population description and HCV prevalence

  2000cited by this paper
• The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates.

  2000cited by this paper
• Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus

  2000cited by this paper
• Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group.

  2000cited by this paper
• Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

  2000cited by this paper
• Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni.

  2000cited by this paper
• Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients.

  2000cited by this paper
• Liver‐Derived Hepatitis C Virus (HCV)‐Specific CD4+ T Cells Recognize Multiple HCV Epitopes and Produce Interferon Gamma

  2000cited by this paper
• Cytokines in Viral Hepatitis

  1999cited by this paper
• Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers.

  1999cited by this paper
• Association between Virus-Specific Cytotoxic T-Lymphocyte and Helper Responses in Human Immunodeficiency Virus Type 1 Infection

  1999cited by this paper
• Role of the specific T‐cell response for clearance and control of hepatitis C virus

  1999cited by this paper
• Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C.

  1999cited by this paper
• Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.

  1999cited by this paper
• Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence

  1999cited by this paper
• The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses

  1998cited by this paper
• The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome.

  1998cited by this paper
• Coinfection by hepatitis B virus and hepatitis C virus.

  1998cited by this paper
• Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation.

  1998cited by this paper
• Interleukin-10-mediated T cell apoptosis during the T helper type 2 cytokine response in murine Schistosoma mansoni parasite infection.

  1997cited by this paper
• Detection of type 2‐like T‐helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity

  1997cited by this paper
• Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections.

  1997cited by this paper
• Cytokine Regulation of Human Immune Response to Schistosoma mansoni: Analysis of the Role of IL‐4, IL‐5 and IL‐10 on Peripheral Blood Mononuclear Cell Responses

  1997cited by this paper
• Epidemiology of hepatitis C

  1997cited by this paper
• Natural history of hepatitis C

  1997cited by this paper
• Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.

  1997cited by this paper
• CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes.

  1997cited by this paper
• The role of immune responses in the pathogenesis of hepatitis C virus infection

  1997cited by this paper
• The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C

  1996cited by this paper
• Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.

  1996cited by this paper
• Early IL-4 production by non-CD4+ cells at the site of antigen deposition predicts the development of a T helper 2 cell response to Schistosoma mansoni eggs.

  1995cited by this paper
• Hepatitis C virus infection in schistosomiasis mansoni in Brazil

  1995cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• High seroprevalence of hepatitis C infection among risk groups in Egypt.

  1994cited by this paper
• Antibodies and viremia in acute post‐transfusion hepatitis C: A prospective study

  1994cited by this paper
• Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts.

  1985cited by this paper
• Epidemiology of hepatitis.

  1965cited by this paper

• Evaluation of APRI Score-based hepatic fibrosis and cirrhosis among hepatitis C patients co-infected with schistosomiasis

  2025cites this paper
• Can Schistosoma japonicum infection cause liver cancer?

  2025cites this paper
• Influence of intestinal schistosome and hepatitis B or C coinfection on hepatic disease: a systematic review and meta-analysis

  2025cites this paper
• Modeling the spread of hepatitis C virus amongst people who inject drugs

  2022cites this paper
• Effects of schistosomes on host anti-viral immune response and the acquisition, virulence, and prevention of viral infections: A systematic review

  2021influential citation
• A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis

  2021cites this paper
• Inflammatory bowel disease in Africa: what is the current state of knowledge?

  2020cites this paper
• Viral Hepatitis

  2020cites this paper
• SCHSITOSOMA MANSONI CO-INFECTION WITH HEPATITIS C VIRUS IS ASSOCIATED WITH INCREASED INTERLEUKIN-28B PLASMA LEVELS IN EGYPTIAN POPULATION

  2020cites this paper
• Impact of chronic schistosomiasis and HBV/HCV co-infection on the liver: current perspectives

  2019cites this paper
• Antioxidant effects of gold nanoparticles on Schistosoma mansoni induced granuloma, in vitro

  2019cites this paper
• Impact of chronic schistosomiasis and HBV/HCV co-infection on the liver: current perspectives

  2019cites this paper
• Hepatobiliary Tract Infections

  2019cites this paper
• The Course of Hepatitis C Infection and Response to Anti-viral Therapy in Patients with Thalassemia major and Hepatitis C Infection: A Longitudinal, Prospective Study

  2019cites this paper
• The role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B

  2019cites this paper
• Hepatitis C and Helminthic Infections

  2018cites this paper
• Hepatitis C and Schistosomiasis Coinfection

  2018cites this paper
• The Role of Fibroscan as a Non-Invasive Predictor for Oesophageal Varices in Post HCV Cirrhotic Egyptian Patients With or Without Bilhariziasis

  2018cites this paper
• Human Cytomegalovirus as a driving force towards Immunosenescence

  2018cites this paper
• Epidemiological determinants correlating hepatitis C and Schistosomiasis mansoni in one of Upper Egypt governorates

  2018cites this paper
• Hepatitis C virus infection

  2017cites this paper
• Schistosomiasis and hepatitis B co-infection

  2017cites this paper
• Co-infection of Schistosoma mansoni/hepatitis C virus and their associated factors among adult individuals living in fishing villages, north-western Tanzania

  2017cites this paper
• Salmonella typhimurium Infection Reduces Schistosoma japonicum Worm Burden in Mice

  2017cites this paper
• Response to Hepatitis B Vaccine in Egyptian Chronic Hepatitis C Patients

  2017cites this paper
• Biochemical and Histopatholigcal changes in Egyptian patients with Hepatitis C and Bilharziasis

  2016cites this paper
• Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.

  2016cites this paper
• EUROPEAN ACADEMIC RESEARCH, VOL

  2016cites this paper
• ESPECIAL Schistosomiasis mansoni – Clinical features

  2015cites this paper
• Schistosomiasis, hepatitis B and hepatitis C co-infection

  2015influential citation
• 156 – Hepatitis C

  2015cites this paper
• Target Population : patients with acute hepatitis C virus infection Setting :

  2015cites this paper
• Role of fibroscan, TGF-&bgr;1, and YKL-40 in the detection of hepatic fibrosis in chronic hepatitis c patients with and without schistosomiasis

  2015cites this paper
• Schistosome infection aggravates HCV‐related liver disease and induces changes in the regulatory T‐cell phenotype

  2015cites this paper
• Studies on the genomic association between schistosomiasis and hepatitis C virus infection

  2015cites this paper
• Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents

  2014cites this paper
• Viral Hepatitis A, B, C, D, and E in Refugees (Screening and Clinical Considerations)

  2014cites this paper
• Chronic hepatitis B and liver schistosomiasis: a deleterious association.

  2014cites this paper
• [Characteristics of Acute Hepatitis C].

  2014cites this paper
• Pharmacogenetics of hepatitis C : transition from interferon-based therapies to direct-acting antiviral agents

  2014cites this paper
• Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases

  2014cites this paper
• Bystander chronic infection negatively impacts development of CD8(+) T cell memory.

  2014cites this paper
• Pharmacogenetics of hepatitis C : transition from interferon-based therapies to direct-acting antiviral agents

  2014cites this paper
• Host and Viral Determinants of the Outcome of Exposure to HCV Infection Genotype 4: A Large Longitudinal Study

  2014cites this paper
• The virome in mammalian physiology and disease.

  2014cites this paper
• Taenia crassiceps infection and its excreted/secreted products inhibit STAT1 activation in response to IFN-γ.

  2014cites this paper
• Schistosomiasis does not affect the outcome of HCV infection in genotype 4-infected patients.

  2014cites this paper
• Neglected tropical diseases as a cause of chronic liver disease: the case of Schistosomiasis and Hepatitis C Co‐infections in Egypt

  2013cites this paper
• Plasmodium suppresses T cell responses to heterologous infections by impairing T cell activation

  2013cites this paper
• Richness and Composition of Niche-Assembled Viral Pathogen Communities

  2013cites this paper
• Toll-Like Receptors in Hepatitis C Infection : Implications for Pathogenesis and Treatment 1

  2013cites this paper
• Toll‐like receptors in hepatitis C infection: Implications for pathogenesis and treatment

  2013cites this paper
• Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response.

  2013cites this paper
• Chronic bystander infections and immunity to unrelated antigens.

  2012cites this paper
• STUDY OF THE IMPACT OF ANTIBILHARZIAL ANTIBODIES IN CHRONIC HEPATITIS C VIRUS (CHCV) PATIENTS TREATED WITH PEGULATED INTERFERON AND RIBAVIRIN ON EARLY VIROLOGICAL RESPONSE (EVR)

  2012cites this paper
• Impact of Helicobacter pylori infection on liver fibrosis in Egyptian patients with chronic hepatitis C

  2012cites this paper
• Case definitions for acute hepatitis C virus infection: a systematic review.

  2012cites this paper
• Management of hepatitis C virus genotype 4: recommendations of an international expert panel.

  2011cites this paper
• Schistosome: Its Benefit and Harm in Patients Suffering from Concomitant Diseases

  2011cites this paper
• The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report

  2010cites this paper
• Schistosoma mansoni soluble egg antigens enhance HCV replication in mammalian cells.

  2010cites this paper
• Viral diversity and prevalence gradients in North American Pacific Coast grasslands.

  2010cites this paper
• A suggested algorithm for using serum biomarkers for the diagnosis of liver fibrosis in chronic hepatitis C infection

  2010cites this paper
• Effects of Peg-Interferon-Alpha-2A on Schistosoma mansoni Infection in Mice

  2010cites this paper
• The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection

  2010cites this paper
• Helminth Infection Can Reduce Insulitis and Type 1 Diabetes through CD25- and IL-10-Independent Mechanisms

  2009cites this paper
• The immunomodulatory properties of helminth-derived products on dendritic cell maturation and function

  2009cites this paper
• Clinical features of biochemical cholestasis in patients with recurrent hepatitis C after living‐donor liver transplantation

  2009cites this paper
• Diversity and Composition of Viral Communities: Coinfection of Barley and Cereal Yellow Dwarf Viruses in California Grasslands

  2009cites this paper
• Hepatitis C genotype 4 therapy: increasing options and improving outcomes

  2009cites this paper
• HCV‐specific T‐cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance

  2008cites this paper
• Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants.

  2008cites this paper
• Seroprevalence and Risk Factors for Human Herpesvirus 8 Infection , Rural Egypt 1

  2008cites this paper
• Hepatic inflammatory cytokine mRNA expression in hepatitis C virus–human immunodeficiency virus co‐infection

  2008cites this paper
• Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection.

  2008cites this paper
• Inflammation and Repair in Viral Hepatitis C

  2008cites this paper
• Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis.

  2008cites this paper
• Very early viral kinetics on interferon treatment in chronic hepatitis C virus genotype 4 infection.

  2008cites this paper
• Hepatitis C genotype 4: What we know and what we don't yet know

  2008cites this paper
• Immune responses during acute and chronic infection with hepatitis C virus.

  2008cites this paper
• Acute Hepatitis C: A Systematic Review

  2008cites this paper
• Increased soluble IL-2 receptor levels during interferon and ribavirin treatment are associated with a good response in genotype 2a/2b patients with chronic hepatitis C

  2008cites this paper
• Immunization with a recombinant fowlpox virus expressing a hepatitis C virus core–E1 polyprotein variant, protects mice and African green monkeys (Chlorocebus aethiops sabaeus) against challenge with a surrogate vaccinia virus

  2008cites this paper
• Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern China.

  2008cites this paper
• New insights in the immunology of viral hepatitis B and C

  2008cites this paper
• Étude de l'autoimmunité contre le foie induite par mimétisme moléculaire

  2008cites this paper
• Very Early Viral Kinetics on Interferon Treatment in Chronic Hepatitis C virus Genotype 4 Infection

  2008cites this paper
• Defective T helper response of hepatocyte-stimulated CD4 T cells impairs antiviral CD8 response and viral clearance.

  2007cites this paper
• Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.

  2007cites this paper
• Immunoparasitological Study in Bilharzial Patients With or without Hepatitis C Virus in El-Beheira Governorate

  2007influential citation
• Improving Outcome in Patients With Hepatitis C Virus Genotype 4

  2007cites this paper
• Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection.

  2007cites this paper
• Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.

  2006cites this paper
• Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

  2006cites this paper
• Th1 response during ribavirin and interferon-α combination therapy in chronic hepatitis C

  2006cites this paper
• Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy.

  2006cites this paper
• Ii-Key/MHC class II epitope hybrids: a strategy that enhances MHC class II epitope loading to create more potent peptide vaccines

  2006cites this paper
• Duration of peginterferon therapy in acute hepatitis C: A randomized trial

  2006cites this paper
• Th1 response during ribavirin and interferon-alpha combination therapy in chronic hepatitis C.

  2006cites this paper
• Liver disease in Egypt: Hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors

  2006cites this paper